| Author | Message | ||
Bongaram Megastar Username: Bongaram Post Number: 22852 Registered: 04-2013 Posted From: 103.252.24.98 Rating: N/A |
Y govt has to involve for the sake of one company? Something fishy. | ||
Bluelagoon Side Hero Username: Bluelagoon Post Number: 4387 Registered: 12-2013 Posted From: 183.82.194.189 Rating: N/A |
dismiss chesindhi love affir issue meedha 2011 vaaadu revenge tho alladi poyi untadu ila complaint cheya avcchu ania adiki bulb 2014 lo veligi untadhi AYINA INDIAN GOVT BEHAVIOUR DISGUSTING amam pranaalu poye drugs medha MODI emira idhi | ||
Nice Hero Username: Nice Post Number: 10764 Registered: 05-2009 Posted From: 115.112.100.10 Rating: N/A |
dismiss chesindhi love affair gurinchi, ee vishayam medha kaadhu Aa candidate ki bulb ippudu eligindhi emo ila kummachu company ni ani. Lekapothe all of a suddent oka company ki sambandinchina 700 products medha ban ante chinna vishayam kaadhu kadha | ||
Tilak Legend Username: Tilak Post Number: 32760 Registered: 02-2012 Posted From: 183.83.48.170 Rating: N/A |
Sodhi lo news la undi .. 2011 lo vaadini dismiss chesaru .. emails must have been sent before 2011 .. right?? 2015 lo drugs ban chesara? Illogical .. Narendra Modi, Pradhan Mantri, Bharata Ganarajya - www.pmindia.nic.in - www.narendramodi.in | ||
Bluelagoon Side Hero Username: Bluelagoon Post Number: 4378 Registered: 12-2013 Posted From: 183.82.194.189 Rating: N/A |
vedhavadhi oka sodhilo REGULATIONS paatinchani prajala pranaalni endanger chese company kosam FREE TRADE TALKS ni vayidha vesthara no DOUBU SUIT BOOT SARKAR idhi anukovalsi vasthondhi | ||
Ramramesh Side Hero Username: Ramramesh Post Number: 5502 Registered: 03-2014 Posted From: 46.165.220.224 Rating: N/A |
Why is the Indian govt supporting a company making medicines with sub-standard and questionable research? So, it is ok to produce sub-standard medicine as long the India Govt. rakes in the tax bonanza? Where's the concern for the health of Indian public??!! No wonder, ppl use so many antibiotics in India, bcoz some of the antibiotics simply don't even work!! On a side-note, if it works out well, this dismissed employee might make decent money in US due to the whistle blower law if he gets a good lawyer, | ||
Rgb Side Hero Username: Rgb Post Number: 2018 Registered: 06-2014 Posted From: 162.115.236.103 Rating: N/A |
Yeah ii madhya drug studies kooda chestunnaru. First of all minimal dabbulu icchi poor people meedha trials As with anything else in India, some companies resort to heavy manipulation of data. I am sure more of these things will come into the open | ||
Aggipidugu116 Junior Artist Username: Aggipidugu116 Post Number: 468 Registered: 07-2014 Posted From: 96.227.101.201 Rating: N/A |
mana bangaram manchidi kaadu anukunta.. FDA kani pettindi.. just like VW case.... India lo QA for pharma is dangerous anukuntnna..I think they can easily cookup results..ethics takkuva.. pattukunna 1000 rupees fine vestaru.. US lo ayite tappu pattukunte 10 Billion+ bokka minimum.. pfzier lanti companies ikkada 10's of billions kahrchupedataru .. antha veazy kaadu.. | ||
Rajusk Legend Username: Rajusk Post Number: 41559 Registered: 02-2008 Posted From: 172.56.35.229 Rating: N/A |
tween January and October 2013, the whistle-blower sent 15 emails to the United States Food & Drug Administration (USFDA), the World Health Organization (WHO), the Austrian Agency for Health and Food Safety (AGES) and the National Agency for Medicines and Health Products Safety (ANSM), requesting them to audit the facility. The emails have been seen by The Hindu. “After thorough internal investigations on the anonymous emails, GVK Biosciences filed a police complaint,” added the spokesperson. Citing his reasons for the revelations in one of the 15 emails to USFDA, the employee wrote, “cruel politics of selfish senior employees” prompted him to complain against GVK Biosciences. Reacting to the ban by European drug regulators, the Commerce Ministry said in a release that it was “disappointed by and concerned” at the ban on “one of the flagship sectors of India”, as the story snowballed into the latest setback to the reputation of India-made generic drugs. | ||
Rajusk Legend Username: Rajusk Post Number: 41558 Registered: 02-2008 Posted From: 172.56.35.229 Rating: N/A |
A torrid love affair between two employees resulted in the international scrutiny of GVK Biosciences and a ban on marketing of around 700 generic drugs tested by the facility. The employee, in love with a junior, left with her in 2011, prompting the girl’s parents to approach the police. As a result, GVK Biosciences — one of the largest Contract Research Organisations based in Hyderabad — dismissed the employee. The police, during the investigation, went through the employee’s emails and found that he had written to every major drug regulatory authority in the world raising doubts about the quality of clinical research conducted at GVK Biosciences. The disgruntled employee’s emails served their intended purpose, at least for him. International medicine agencies sought to inspect GVK Biosciences’ Hyderabad facility and alleged manipulation of data by the organisation. The European Union banned 700 drugs tested by GVK Biosciences in July this year after which the Indian government suspended the EU Free Trade Agreement (EU FTA) talks that were to resume in August after a two-year break |